Clinical Trial

Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

Study acronym: MYE Symphony
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
MYE Symphony is a multicenter, open-label, Phase 1 first-in-human study to assess the safety, tolerability, and define the RP2D of MT-302 in participants with advanced epithelial cancer.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-07-28; most recent amendment 2024-01-16.
Status change: Not Yet Recruiting → Recruiting 2023-08-01
Trial Details
NCT Number NCT05969041
Lead Sponsor Myeloid Therapeutics
Conditions Epithelial Tumors, Malignant
Enrollment 48 participants
Start Date 2023-08-02
Primary Completion 2027-08-31 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2024-01-18